Elevance Health
1,602 hedge funds and large institutions have $76.5B invested in Elevance Health in 2024 Q4 according to their latest regulatory filings, with 221 funds opening new positions, 472 increasing their positions, 735 reducing their positions, and 281 closing their positions.
9% more call options, than puts
Call options by funds: $677M | Put options by funds: $619M
0.4% more ownership
Funds ownership: 89.24% → 89.64% (+0.4%)
5% less funds holding
Funds holding: 1,693 → 1,602 (-91)
21% less first-time investments, than exits
New positions opened: 221 | Existing positions closed: 281
25% less funds holding in top 10
Funds holding in top 10: 51 → 38 (-13)
28% less capital invested
Capital invested by funds: $107B → $76.5B (-$30.4B)
36% less repeat investments, than reductions
Existing positions increased: 472 | Existing positions reduced: 735
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$793M |
| 2 |
Harris Associates
Chicago,
Illinois
|
+$762M |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$529M |
| 4 |
First Eagle Investment Management
New York
|
+$435M |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$375M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02B |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$784M |
| 3 |
JP Morgan Chase
New York
|
-$394M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$357M |
| 5 |
Goldman Sachs
New York
|
-$295M |
ELV Hedge Fund Activity: Q4 2024 in Review
1,602 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2024, worth a combined $76.5B — down 28% from $107B a quarter earlier.
Sellers outnumbered buyers: 281 funds closed out of ELV and 221 opened new positions — a net loss of 60 holders — while 735 trimmed existing stakes and 472 added.
The largest buyer was Wellington Management Group, adding an estimated $793M. The largest seller was Fidelity Investments, cutting an estimated $1.02B.
- 1,602 institutional investors held Elevance Health (ELV) as of Q4 2024, down from 1,693 in Q3 2024.
- Funds reported $76.5B of Elevance Health stock for Q4 2024, down 28% quarter-over-quarter.
- 221 funds opened new Elevance Health positions in Q4 2024 and 281 closed out, a net change of -60 holders.
- The largest Elevance Health buyer in Q4 2024 was Wellington Management Group, an estimated $793M added.
- The largest Elevance Health seller in Q4 2024 was Fidelity Investments, an estimated $1.02B sold.
Based on aggregated 13F filings for Q4 2024.